BTIG Reiterates Buy Rating for Nektar Therapeutics, Raises PT to $118.

jueves, 29 de enero de 2026, 12:01 pm ET1 min de lectura
NKTR--

BTIG Reiterates Buy Rating for Nektar Therapeutics, Raises PT to $118.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios